Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
19296
1.40%
-0.21%
0.30%
Apr 2025
Nippon India Multi Asset Allocation Fund Direct - Growth
6826
0.07%
-0.20%
-0.18%
Apr 2025
Sundaram Dividend Yield Fund Direct-Growth
15333
1.03%
0.11%
0.32%
Apr 2025
Aditya Birla Sun Life India GenNext Direct Fund-Growth
75252
0.75%
-0.03%
0.04%
Apr 2025
Baroda BNP Paribas Value Fund Direct - Growth
22000
0.99%
0.03%
0.09%
Apr 2025
Nippon India Pharma Fund Direct-Growth
230272
1.66%
0.03%
0.15%
Apr 2025
Aditya Birla Sun Life Dividend Yield Fund Direct-Growth
19430
0.82%
0.02%
0.09%
Apr 2025
Aditya Birla Sun Life MNC Fund Direct-Growth
46233
0.80%
0.02%
0.08%
Apr 2025
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
26755
0.80%
0.02%
0.80%
Apr 2025
PGIM India Healthcare Fund Direct-Growth
2897
1.60%
0.01%
0.10%
Apr 2025
Nippon India Innovation Fund Direct - Growth
34110
0.84%
-0.01%
0.04%
Apr 2025
Nippon India Multi Cap Fund Direct-Growth
152371
0.22%
-0.01%
0.00%
Apr 2025
Aditya Birla Sun Life Mid Cap Direct Fund-Growth
64630
0.68%
0.01%
0.04%
Apr 2025
Baroda BNP Paribas Midcap Fund Direct-Growth
35000
1.02%
0.01%
0.40%
Apr 2025
Mirae Asset Nifty Total Market Index Fund Direct-Growth
18
0.03%
0.00%
0.00%
Apr 2025
Axis Nifty 500 Index Fund Direct-Growth
0
0.00%
0.00%
-0.03%
Apr 2025
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0
0.00%
0.00%
-0.30%
Apr 2025
Bandhan Nifty Total Market Index Fund Direct-Growth
18
0.03%
0.00%
0.00%
Apr 2025
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Bajaj Finserv Flexi Cap Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0
0.00%
0.00%
-0.30%
Apr 2025
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0
0.00%
0.00%
-0.30%
Apr 2025
Groww Nifty Total Market Index Fund Direct - Growth
139
0.03%
0.00%
0.00%
Apr 2025
About Sanofi
Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products include Lantus (insulin), Combiflam (pain relief), Amaryl (anti-diabetic), Allegra (allergy), Cardace (cardiovascular), and Toujeo (long-acting insulin). Sanofi India is majority-owned by Sanofi and its subsidiary Hoechst GmbH, holding 60.37% of its paid-up share capital. The company has undergone several name changes and acquisitions, including the purchase of Universal Medicare's nutraceutical business in 2011. In 2021, Sanofi India sold its Nutraceuticals business to Universal Nutriscience Private Limited, and in 2022-23, its Consumer Healthcare Business was demerged into a wholly-owned subsidiary.